Connor, Clark & Lunn Investment Management (CC&L)’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Sell |
|
|||||
|
2025
Q1 | $1.32M | Sell |
|
|||||
|
2024
Q4 | $2.25M | Buy |
|
|||||
|
2024
Q3 | $382K | Buy |
|
|||||
|
2024
Q2 | $127K | Buy |
|
|||||
|
2024
Q1 | $125K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $1.38M | Sell |
|
|||||
|
2023
Q2 | $2.19M | Buy |
|
|||||
|
2023
Q1 | $1.43M | Buy |
|
|||||
|
2022
Q4 | $265K | Sell |
|
|||||
|
2022
Q3 | $423K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $81K | Buy |
|